Analytical Data
-
基因名
MT2731
- Application
-
别名
MT2731；
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P9WJ10
-
表达区间
1-81aa
-
氨基酸序列
MSGHALAARTLLAAADELVGGPPVEASAAALAGDAAGAWRTAAVELARALVRAVAESHGVAAVLFAATAAAAAAVDRGDPP
-
分子量
9.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MT2731 is a recombinant protein that has garnered interest in the field of biotechnology due to its potential applications in various biological and pharmaceutical processes. The protein is derived from a specific microbial source, known for its unique properties that can be harnessed for therapeutic purposes. Research into MT2731 explores its structure, function, and mechanisms of action, particularly regarding its role in enzyme catalysis and cellular processes. Studies suggest that MT2731 may exhibit antioxidant activity, which can protect cells from oxidative stress and inflammation, making it a candidate for developing treatments for diseases associated with such conditions. Furthermore, understanding the gene expression and regulatory mechanisms underlying MT2731 production could contribute significantly to optimizing industrial processes for protein synthesis. As the demand for biopharmaceuticals continues to rise, exploring recombinant proteins like MT2731 provides opportunities for innovation in drug development and regenerative medicine. Scientists are increasingly focusing on the protein's stability, efficacy, and safety through various purification and characterization techniques. The ongoing research not only aims to elucidate MT2731's biochemical pathways but also seeks to harness its properties for therapeutic applications, emphasizing the critical intersection of molecular biology and engineering in advancing modern medicine.
